Genfit S.A. GNFT 深 滬
已收盤 10-24 16:00:00 美东时间
4.30
0.000
0.00%
華盛通- 最 高4.40
- 今 開4.40
- 成交量 1609股
- 最 低 4.30
- 昨 收 4.30
- 總市值 2.15亿
- 52周最高 6.0298
- 市盈率 靜 131.90
- 換手率 0.00%
- 52周最低 2.55
- 委 比 76.44%
- 總股本 5000.29万
- 歷史最高 26.25
- 量 比 0.63
- 振 幅 2.33%
- 歷史最低 2.55
- 每 手 1
- 風險率 0.51%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sagimet rises after denifanstat succeeds in late stage trial
Sagimet Biosciences (NASDAQ:SGMT) announced positive results from a late-stage trial of denifanstat, a treatment for moderate to severe acne vulgaris, which was conducted by its partner, Ascletis Bios...
10-24 21:37
Viking Therapeutics, Genfit, Sagimet jump as Novo to buy Akero
Viking Therapeutics (NASDAQ:VKTX) and other biotechs advancing drugs for a liver disease called metabolic dysfunction-associated steatohepatitis (MASH) gained on Thursday as the MASH space witnessed t...
10-09 23:33
美股大行评级 | 217美元！花旗上调阿里巴巴目标价；多家机构集体上调麦克森、美光科技等目标价
今日重点评级关注：Ascendiant Capital：维持Maison Solutions"买入"评级，目标价从4美元升至4.25美元；瑞穗：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至56美元
09-25 09:52
Genfit S.A. GAAP EPS of -€0.20, revenue of €35.67M
Genfit S.A. press release (OTCPK:GNFTF): 1H GAAP EPS of -€0.20. Revenue of €35.67M (-41.7% Y/Y). Cash and cash equivalents totaled €107.5 million as of June 30, 2025, excluding the €26.5 million miles...
09-23 12:52
Genfit SA Reports Revenue Decline and Net Loss
Genfit SA ( ($GNFTF) ) has released its Q2 earnings. Here is a breakdown of the...
09-23 11:52
GENFIT S.A. Releases Half-Year Financial Report for 2025
An update from Genfit SA ( ($GNFT) ) is now available. On September 22, 2025, G...
09-23 04:47
GENFIT’s Strategic Shift and Financial Update for H1 2025
Genfit SA ( ($GNFT) ) has shared an update. On September 22, 2025, GENFIT annou...
09-23 04:28
Genfit H1 EPS $(0.23) Down From $0.57 YoY, Sales $40.443M Down From $65.887M YoY
Genfit (NASDAQ:GNFT) reported quarterly losses of $(0.23) per share. This is a 140.35 percent decrease over earnings of $0.57 per share from the same period last year. The company reported $40.443 million in sales this
09-23 04:11
Earnings Scheduled For September 22, 2025
Companies Reporting Before The Bell Companies Reporting After The Bell • Genfit...
09-22 16:32
Genfit Announces Discontinuation Of Its VS-01 Program In ACLF: VS-01 Development Refocused On UCD; Says Following Discontinuation Of Our VS-01 Program In ACLF, We Anticipate A Substantial Reduction In Our Operating Expenses
GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCDLille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), September 19, 2025 - GENFIT (Nasdaq and
09-20 04:17
